The article you requested is
Voltage-Gated Potassium Channel/LGI1 Antibody–Associated Encephalopathy May Cause Brief Psychotic Disorder
J Clin Psychiatry 2011;72(5):722-723 [letter]
Copyright 2011 Physicians Postgraduate Press, Inc.
To view this item, select one of the options below.
Purchase this PDF for $40
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP print + online for $166 individual.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send an email
Letter to the Editor
Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.
Voltage-gated potassium channel (VGKC) antibody–associated encephalopathy has been identified as a potentially immunotherapy-responsive form of limbic encephalitis. A recent study showed that the target antigen in this condition is in fact LGI1, a secreted neural protein that functions as a ligand for 2 epilepsy-related proteins, ADAM22 and ADAM23. Limbic encephalitis is typically a paraneoplastic syndrome with a poor prognosis.